Literature DB >> 33596864

Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains.

Manon Oliero1,2, Annie Calvé1, Gabriela Fragoso1, Thibault Cuisiniere1, Roy Hajjar1,3, Ulrich Dobrindt4, Manuela M Santos5,6.   

Abstract

BACKGROUND: Colibactin is a genotoxin that induces DNA double-strand breaks that may lead to carcinogenesis and is produced by Escherichia coli strains harboring the pks island. Human and animal studies have shown that colibactin-producing gut bacteria promote carcinogenesis and enhance the progression of colorectal cancer through cellular senescence and chromosomal abnormalities. In this study, we investigated the impact of prebiotics on the genotoxicity of colibactin-producing E. coli strains Nissle 1917 and NC101.
METHODS: Bacteria were grown in medium supplemented with 20, 30 and 40 mg/mL of prebiotics inulin or galacto-oligosaccharide, and with or without 5 μM, 25 μM and 125 μM of ferrous sulfate. Colibactin expression was assessed by luciferase reporter assay for the clbA gene, essential for colibactin production, in E. coli Nissle 1917 and by RT-PCR in E. coli NC101. The human epithelial colorectal adenocarcinoma cell line, Caco-2, was used to assess colibactin-induced megalocytosis by methylene blue binding assay and genotoxicity by γ-H2AX immunofluorescence analysis.
RESULTS: Inulin and galacto-oligosaccharide enhanced the expression of clbA in pks+ E. coli. However, the addition of 125 μM of ferrous sulfate inhibited the expression of clbA triggered by oligosaccharides. In the presence of either oligosaccharide, E. coli NC101 increased dysplasia and DNA double-strand breaks in Caco-2 cells compared to untreated cells.
CONCLUSION: Our results suggest that, in vitro, prebiotic oligosaccharides exacerbate DNA damage induced by colibactin-producing bacteria. Further studies are necessary to establish whether oligosaccharide supplementation may lead to increased colorectal tumorigenesis in animal models colonized with pks+ E. coli.

Entities:  

Keywords:  Colibactin; Colorectal cancer; E. coli; Galacto-oligosaccharides; Genotoxin; Inulin; Iron

Year:  2021        PMID: 33596864     DOI: 10.1186/s12885-021-07876-8

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  33 in total

1.  Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli.

Authors:  Cayetano Pleguezuelos-Manzano; Jens Puschhof; Axel Rosendahl Huber; Arne van Hoeck; Henry M Wood; Jason Nomburg; Carino Gurjao; Freek Manders; Guillaume Dalmasso; Paul B Stege; Fernanda L Paganelli; Maarten H Geurts; Joep Beumer; Tomohiro Mizutani; Yi Miao; Reinier van der Linden; Stefan van der Elst; K Christopher Garcia; Janetta Top; Rob J L Willems; Marios Giannakis; Richard Bonnet; Phil Quirke; Matthew Meyerson; Edwin Cuppen; Ruben van Boxtel; Hans Clevers
Journal:  Nature       Date:  2020-02-27       Impact factor: 49.962

2.  Escherichia coli induces DNA double-strand breaks in eukaryotic cells.

Authors:  Jean-Philippe Nougayrède; Stefan Homburg; Frédéric Taieb; Michèle Boury; Elzbieta Brzuszkiewicz; Gerhard Gottschalk; Carmen Buchrieser; Jörg Hacker; Ulrich Dobrindt; Eric Oswald
Journal:  Science       Date:  2006-08-11       Impact factor: 47.728

3.  Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli.

Authors:  Stefan Homburg; Eric Oswald; Jörg Hacker; Ulrich Dobrindt
Journal:  FEMS Microbiol Lett       Date:  2007-08-22       Impact factor: 2.742

4.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

Review 5.  Control of pathogens and pathobionts by the gut microbiota.

Authors:  Nobuhiko Kamada; Grace Y Chen; Naohiro Inohara; Gabriel Núñez
Journal:  Nat Immunol       Date:  2013-07       Impact factor: 25.606

6.  Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells.

Authors:  Thomas Secher; Ascel Samba-Louaka; Eric Oswald; Jean-Philippe Nougayrède
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

7.  Antibiotic resistance and molecular characterization of bacteremia Escherichia coli isolates from newborns in the United States.

Authors:  Bryan K Cole; Marko Ilikj; Cindy B McCloskey; Susana Chavez-Bueno
Journal:  PLoS One       Date:  2019-07-05       Impact factor: 3.240

Review 8.  Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors.

Authors:  Prashanth Rawla; Tagore Sunkara; Adam Barsouk
Journal:  Prz Gastroenterol       Date:  2019-01-06

9.  High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer.

Authors:  Emmanuel Buc; Damien Dubois; Pierre Sauvanet; Jennifer Raisch; Julien Delmas; Arlette Darfeuille-Michaud; Denis Pezet; Richard Bonnet
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.

Authors:  Wanxin Liu; Ren Zhang; Rong Shu; Jinjing Yu; Huan Li; Hui Long; Shu Jin; Shengbao Li; Qiuyu Hu; Fei Yao; Chuanren Zhou; Qiyou Huang; Xiafen Hu; Meng Chen; Weiguo Hu; Qiang Wang; Shenying Fang; Qingming Wu
Journal:  Biomed Res Int       Date:  2020-01-30       Impact factor: 3.411

View more
  5 in total

1.  Somatic mutation rates scale with lifespan across mammals.

Authors:  Alex Cagan; Adrian Baez-Ortega; Natalia Brzozowska; Federico Abascal; Tim H H Coorens; Mathijs A Sanders; Andrew R J Lawson; Luke M R Harvey; Shriram Bhosle; David Jones; Raul E Alcantara; Timothy M Butler; Yvette Hooks; Kirsty Roberts; Elizabeth Anderson; Sharna Lunn; Edmund Flach; Simon Spiro; Inez Januszczak; Ethan Wrigglesworth; Hannah Jenkins; Tilly Dallas; Nic Masters; Matthew W Perkins; Robert Deaville; Megan Druce; Ruzhica Bogeska; Michael D Milsom; Björn Neumann; Frank Gorman; Fernando Constantino-Casas; Laura Peachey; Diana Bochynska; Ewan St John Smith; Moritz Gerstung; Peter J Campbell; Elizabeth P Murchison; Michael R Stratton; Iñigo Martincorena
Journal:  Nature       Date:  2022-04-13       Impact factor: 69.504

Review 2.  Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer.

Authors:  Julie Veziant; Romain Villéger; Nicolas Barnich; Mathilde Bonnet
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

Review 3.  Preventing Colorectal Cancer through Prebiotics.

Authors:  Manijeh Mahdavi; Isabelle Laforest-Lapointe; Eric Massé
Journal:  Microorganisms       Date:  2021-06-18

Review 4.  Shining a Light on Colibactin Biology.

Authors:  Michael W Dougherty; Christian Jobin
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

5.  Two Polyketides Intertwined in Complex Regulation: Posttranscriptional CsrA-Mediated Control of Colibactin and Yersiniabactin Synthesis in Escherichia coli.

Authors:  Nadine Rehm; Alexander Wallenstein; Marla Keizers; Stefan Homburg; Giuseppe Magistro; Camille V Chagneau; Hanna Klimek; Olga Revelles; Emmanuelle Helloin; Johannes Putze; Jean-Philippe Nougayrède; Sören Schubert; Eric Oswald; Ulrich Dobrindt
Journal:  mBio       Date:  2022-02-01       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.